Possible therapeutic role of a highly standardized mixture of active compounds derived from cultured Lentinula edodes mycelia (AHCC) in patients infected with 2019 novel coronavirus.
Identifieur interne : 000490 ( an2020/Analysis ); précédent : 000489; suivant : 000491Possible therapeutic role of a highly standardized mixture of active compounds derived from cultured Lentinula edodes mycelia (AHCC) in patients infected with 2019 novel coronavirus.
Auteurs : Francesco Di Pierro [Oman] ; Alexander Bertuccioli [Italie] ; Ilaria Cavecchia [Italie]Source :
- Minerva gastroenterologica e dietologica [ 1827-1642 ] ; 2020.
Abstract
The outbreak of SARS-CoV-2 disease (COVID-19) is currently, March 2020, affecting more than 100000 people worldwide and, according to the WHO (World Health Organization), a pandemic is shortly expected. The virus infects the lower respiratory tract and causes severe pneumonia and mortality in approximately 10% and 3-5%, respectively, of cases, mainly among the elderly and/or people affected by other diseases. AHCC is an α-glucan-based standardized mushroom extract that has been extensively investigated as an immunostimulant both in animals and/or in humans affected by West Nile virus, influenza virus, avian influenza virus, hepatitis C virus, papillomavirus, herpes virus, hepatitis B virus and HIV by promoting a regulated and protective immune response. Although the efficacy of AHCC has not yet been specifically evaluated with respect to SARS-CoV-2 disease, its action in promoting a protective response to a wide range of viral infections, and the current absence of effective vaccines, could support its use in the prevention of diseases provoked by human pathogenic coronavirus, including COVID-19.
DOI: 10.23736/S1121-421X.20.02697-5
PubMed: 32162896
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 000614
- to stream PubMed, to step Curation: 000614
- to stream PubMed, to step Checkpoint: 000455
- to stream Ncbi, to step Merge: 000F77
- to stream Ncbi, to step Curation: 000F77
- to stream Ncbi, to step Checkpoint: 000F77
- to stream Main, to step Merge: 000492
- to stream Main, to step Curation: 000490
- to stream Main, to step Exploration: 000490
- to stream an2020, to step Extraction: 000490
Links to Exploration step
pubmed:32162896Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Possible therapeutic role of a highly standardized mixture of active compounds derived from cultured Lentinula edodes mycelia (AHCC) in patients infected with 2019 novel coronavirus.</title><author><name sortKey="Di Pierro, Francesco" sort="Di Pierro, Francesco" uniqKey="Di Pierro F" first="Francesco" last="Di Pierro">Francesco Di Pierro</name><affiliation wicri:level="3"><nlm:affiliation>Scientific & Research Department, Velleja Research, Milan, Italy - f.dipierro@vellejaresearch.com.</nlm:affiliation><country wicri:rule="url">Oman</country><wicri:regionArea>Scientific & Research Department, Velleja Research, Milan</wicri:regionArea><placeName><settlement type="city">Milan</settlement><region nuts="2">Lombardie</region></placeName></affiliation></author><author><name sortKey="Bertuccioli, Alexander" sort="Bertuccioli, Alexander" uniqKey="Bertuccioli A" first="Alexander" last="Bertuccioli">Alexander Bertuccioli</name><affiliation wicri:level="1"><nlm:affiliation>D.I.S.B., Urbino, Italy.</nlm:affiliation><country xml:lang="fr">Italie</country><wicri:regionArea>D.I.S.B., Urbino</wicri:regionArea><wicri:noRegion>Urbino</wicri:noRegion></affiliation></author><author><name sortKey="Cavecchia, Ilaria" sort="Cavecchia, Ilaria" uniqKey="Cavecchia I" first="Ilaria" last="Cavecchia">Ilaria Cavecchia</name><affiliation wicri:level="3"><nlm:affiliation>Scientific & Research Department, Velleja Research, Milan, Italy.</nlm:affiliation><country xml:lang="fr">Italie</country><wicri:regionArea>Scientific & Research Department, Velleja Research, Milan</wicri:regionArea><placeName><settlement type="city">Milan</settlement><region nuts="2">Lombardie</region></placeName></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2020">2020</date><idno type="RBID">pubmed:32162896</idno><idno type="pmid">32162896</idno><idno type="doi">10.23736/S1121-421X.20.02697-5</idno><idno type="wicri:Area/PubMed/Corpus">000614</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000614</idno><idno type="wicri:Area/PubMed/Curation">000614</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000614</idno><idno type="wicri:Area/PubMed/Checkpoint">000455</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000455</idno><idno type="wicri:Area/Ncbi/Merge">000F77</idno><idno type="wicri:Area/Ncbi/Curation">000F77</idno><idno type="wicri:Area/Ncbi/Checkpoint">000F77</idno><idno type="wicri:Area/Main/Merge">000492</idno><idno type="wicri:Area/Main/Curation">000490</idno><idno type="wicri:Area/Main/Exploration">000490</idno><idno type="wicri:Area/an2020/Extraction">000490</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Possible therapeutic role of a highly standardized mixture of active compounds derived from cultured Lentinula edodes mycelia (AHCC) in patients infected with 2019 novel coronavirus.</title><author><name sortKey="Di Pierro, Francesco" sort="Di Pierro, Francesco" uniqKey="Di Pierro F" first="Francesco" last="Di Pierro">Francesco Di Pierro</name><affiliation wicri:level="3"><nlm:affiliation>Scientific & Research Department, Velleja Research, Milan, Italy - f.dipierro@vellejaresearch.com.</nlm:affiliation><country wicri:rule="url">Oman</country><wicri:regionArea>Scientific & Research Department, Velleja Research, Milan</wicri:regionArea><placeName><settlement type="city">Milan</settlement><region nuts="2">Lombardie</region></placeName></affiliation></author><author><name sortKey="Bertuccioli, Alexander" sort="Bertuccioli, Alexander" uniqKey="Bertuccioli A" first="Alexander" last="Bertuccioli">Alexander Bertuccioli</name><affiliation wicri:level="1"><nlm:affiliation>D.I.S.B., Urbino, Italy.</nlm:affiliation><country xml:lang="fr">Italie</country><wicri:regionArea>D.I.S.B., Urbino</wicri:regionArea><wicri:noRegion>Urbino</wicri:noRegion></affiliation></author><author><name sortKey="Cavecchia, Ilaria" sort="Cavecchia, Ilaria" uniqKey="Cavecchia I" first="Ilaria" last="Cavecchia">Ilaria Cavecchia</name><affiliation wicri:level="3"><nlm:affiliation>Scientific & Research Department, Velleja Research, Milan, Italy.</nlm:affiliation><country xml:lang="fr">Italie</country><wicri:regionArea>Scientific & Research Department, Velleja Research, Milan</wicri:regionArea><placeName><settlement type="city">Milan</settlement><region nuts="2">Lombardie</region></placeName></affiliation></author></analytic><series><title level="j">Minerva gastroenterologica e dietologica</title><idno type="eISSN">1827-1642</idno><imprint><date when="2020" type="published">2020</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">The outbreak of SARS-CoV-2 disease (COVID-19) is currently, March 2020, affecting more than 100000 people worldwide and, according to the WHO (World Health Organization), a pandemic is shortly expected. The virus infects the lower respiratory tract and causes severe pneumonia and mortality in approximately 10% and 3-5%, respectively, of cases, mainly among the elderly and/or people affected by other diseases. AHCC is an α-glucan-based standardized mushroom extract that has been extensively investigated as an immunostimulant both in animals and/or in humans affected by West Nile virus, influenza virus, avian influenza virus, hepatitis C virus, papillomavirus, herpes virus, hepatitis B virus and HIV by promoting a regulated and protective immune response. Although the efficacy of AHCC has not yet been specifically evaluated with respect to SARS-CoV-2 disease, its action in promoting a protective response to a wide range of viral infections, and the current absence of effective vaccines, could support its use in the prevention of diseases provoked by human pathogenic coronavirus, including COVID-19.</div></front></TEI><affiliations><list><country><li>Italie</li><li>Oman</li></country><region><li>Lombardie</li></region><settlement><li>Milan</li></settlement></list><tree><country name="Oman"><region name="Lombardie"><name sortKey="Di Pierro, Francesco" sort="Di Pierro, Francesco" uniqKey="Di Pierro F" first="Francesco" last="Di Pierro">Francesco Di Pierro</name></region></country><country name="Italie"><noRegion><name sortKey="Bertuccioli, Alexander" sort="Bertuccioli, Alexander" uniqKey="Bertuccioli A" first="Alexander" last="Bertuccioli">Alexander Bertuccioli</name></noRegion><name sortKey="Cavecchia, Ilaria" sort="Cavecchia, Ilaria" uniqKey="Cavecchia I" first="Ilaria" last="Cavecchia">Ilaria Cavecchia</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/CovidV2/Data/an2020/Analysis
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000490 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/an2020/Analysis/biblio.hfd -nk 000490 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= CovidV2
|flux= an2020
|étape= Analysis
|type= RBID
|clé= pubmed:32162896
|texte= Possible therapeutic role of a highly standardized mixture of active compounds derived from cultured Lentinula edodes mycelia (AHCC) in patients infected with 2019 novel coronavirus.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/an2020/Analysis/RBID.i -Sk "pubmed:32162896" \
| HfdSelect -Kh $EXPLOR_AREA/Data/an2020/Analysis/biblio.hfd \
| NlmPubMed2Wicri -a CovidV2
| This area was generated with Dilib version V0.6.33. |  |